ATE295157T1 - Mittel zur transdermalen verabreichung von arzneistoffen - Google Patents
Mittel zur transdermalen verabreichung von arzneistoffenInfo
- Publication number
- ATE295157T1 ATE295157T1 AT97901642T AT97901642T ATE295157T1 AT E295157 T1 ATE295157 T1 AT E295157T1 AT 97901642 T AT97901642 T AT 97901642T AT 97901642 T AT97901642 T AT 97901642T AT E295157 T1 ATE295157 T1 AT E295157T1
- Authority
- AT
- Austria
- Prior art keywords
- medicinal
- agent
- drug
- transdermal administration
- medicine
- Prior art date
Links
- 229940079593 drug Drugs 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- 150000002500 ions Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000000835 fiber Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- YLJREFDVOIBQDA-UHFFFAOYSA-N tacrine Chemical compound C1=CC=C2C(N)=C(CCCC3)C3=NC2=C1 YLJREFDVOIBQDA-UHFFFAOYSA-N 0.000 abstract 1
- 229960001685 tacrine Drugs 0.000 abstract 1
- 239000004753 textile Substances 0.000 abstract 1
- 230000037317 transdermal delivery Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI960435A FI960435A7 (fi) | 1996-01-30 | 1996-01-30 | Lääkkeiden transdermaalisen antotapaan tarkoitettu koostumus |
| FI962450A FI962450A0 (fi) | 1996-06-12 | 1996-06-12 | Farmaceutisk sammansaettning och foerfarande foer dosering av laekemedel |
| PCT/FI1997/000039 WO1997027844A1 (en) | 1996-01-30 | 1997-01-27 | Composition for transdermal delivery of drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE295157T1 true ATE295157T1 (de) | 2005-05-15 |
Family
ID=26160098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97901642T ATE295157T1 (de) | 1996-01-30 | 1997-01-27 | Mittel zur transdermalen verabreichung von arzneistoffen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6254883B1 (de) |
| EP (1) | EP0942716B1 (de) |
| JP (1) | JP2000504002A (de) |
| AT (1) | ATE295157T1 (de) |
| CA (1) | CA2242753A1 (de) |
| DE (1) | DE69733268T2 (de) |
| WO (1) | WO1997027844A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI107372B (fi) * | 1999-04-29 | 2001-07-31 | Novagent Oy | Laite vaikuttavan aineen annosteluun ja annostelun tutkimukseen |
| EP1480527A4 (de) * | 2002-02-13 | 2005-03-30 | Beek Global Ninkov L L C Van | Zusammensetzungen und verfahren zur erhöhung der milchproduktion bei tieren |
| WO2007078007A1 (ja) * | 2006-01-06 | 2007-07-12 | Japan Science And Technology Agency | カーボンナノホーン構造体並びにその内在有機物の放出を制御可能とする組成物とその方法 |
| JP5558096B2 (ja) | 2007-03-01 | 2014-07-23 | 株式会社日本触媒 | 吸水性樹脂を主成分とする粒子状吸水剤 |
| CN101641153B (zh) | 2007-04-05 | 2012-08-15 | 株式会社日本触媒 | 以吸水性树脂为主成分的粒子状吸水剂 |
| KR101619865B1 (ko) * | 2010-07-30 | 2016-05-11 | 이엠디 밀리포어 코포레이션 | 크로마토그래피 매질 |
| FI125075B (fi) | 2012-08-13 | 2015-05-29 | Novagent Oy | Vaikuttavan aineen iontoforeettinen annostelujärjestelmä |
| WO2014165971A1 (en) * | 2013-04-10 | 2014-10-16 | Glycobiosciences, Inc. | Topical nutraceutical composition |
| EP3188816B1 (de) | 2014-09-02 | 2021-06-09 | EMD Millipore Corporation | Chromatographie-medum, bestehend aus diskreten porösen bündeln von nanofibrillen |
| US9669012B2 (en) | 2014-10-30 | 2017-06-06 | Textile-Based Delivery, Inc. | Delivery systems |
| EP3230299A1 (de) | 2014-12-08 | 2017-10-18 | EMD Millipore Corporation | Mischbettionenaustauschadsorber |
| EP4534118A3 (de) * | 2020-06-24 | 2025-06-11 | Anika Therapeutics, Inc. | Medizinische verbundtextilie mit nichtresorbierbaren fasern und bioresorbierbaren hyaluronanbasierten fasern |
| US12514756B1 (en) | 2024-10-08 | 2026-01-06 | Covidien Lp | Dermal patch and systems, kits, and methods associated therewith |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE603705C (de) | 1931-06-18 | 1934-10-08 | Desider Deutsch Dr | Elektrode zur Einfuehrung von Heilmitteln in den Koerper mittels Iontophorese |
| FI52816C (fi) | 1974-03-28 | 1983-05-10 | Exel Oy | Trissa foer skidstav |
| US4032452A (en) | 1975-11-13 | 1977-06-28 | Sybron Corporation | Electrically regenerated ion exchange system |
| US4585652A (en) | 1984-11-19 | 1986-04-29 | Regents Of The University Of Minnesota | Electrochemical controlled release drug delivery system |
| US4692462A (en) | 1985-03-18 | 1987-09-08 | Menley & James Laboratories, Ltd. | Compositions and method of controlling transdermal penetration of topical and systemic agents |
| US4731049A (en) | 1987-01-30 | 1988-03-15 | Ionics, Incorporated | Cell for electrically controlled transdermal drug delivery |
| US5080646A (en) | 1988-10-03 | 1992-01-14 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
| US5162042A (en) | 1988-07-05 | 1992-11-10 | Alza Corporation | Electrotransport transdermal system |
| US5098417A (en) * | 1990-04-12 | 1992-03-24 | Ricoh Kyosan, Inc. | Cellulosic wound dressing with an active agent ionically absorbed thereon |
| US5147297A (en) | 1990-05-07 | 1992-09-15 | Alza Corporation | Iontophoretic delivery device |
| AU1586692A (en) | 1991-03-11 | 1992-10-06 | Alza Corporation | Iontophoretic delivery device and method of making same |
| AU5354994A (en) | 1992-10-15 | 1994-05-09 | Alza Corporation | Delayed onset transdermal delivery device |
| US5603955A (en) | 1994-07-18 | 1997-02-18 | University Of Cincinnati | Enhanced loading of solutes into polymer gels |
| WO1996010441A1 (en) | 1994-09-30 | 1996-04-11 | Becton Dickinson And Company | Iontophoretic drug delivery system, including disposable patch and reusable, removable controller |
| WO1996010439A1 (en) | 1994-09-30 | 1996-04-11 | Kabushiki Kaisya Advance | Interface for iontophoretic percutaneous administration, and agent and method for treating the skin for that purpose |
-
1997
- 1997-01-27 WO PCT/FI1997/000039 patent/WO1997027844A1/en not_active Ceased
- 1997-01-27 DE DE69733268T patent/DE69733268T2/de not_active Expired - Lifetime
- 1997-01-27 US US09/101,333 patent/US6254883B1/en not_active Expired - Lifetime
- 1997-01-27 JP JP9527325A patent/JP2000504002A/ja active Pending
- 1997-01-27 AT AT97901642T patent/ATE295157T1/de not_active IP Right Cessation
- 1997-01-27 CA CA002242753A patent/CA2242753A1/en not_active Abandoned
- 1997-01-27 EP EP97901642A patent/EP0942716B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000504002A (ja) | 2000-04-04 |
| DE69733268T2 (de) | 2006-01-19 |
| WO1997027844A1 (en) | 1997-08-07 |
| CA2242753A1 (en) | 1997-08-07 |
| DE69733268D1 (de) | 2005-06-16 |
| EP0942716A1 (de) | 1999-09-22 |
| EP0942716B1 (de) | 2005-05-11 |
| US6254883B1 (en) | 2001-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI943430A7 (fi) | Lääkkeenantojärjestelmä entsyymeillä ja valolle aktivoitavien lääkkeiden samanaikaiseksi vapauttamiseksi | |
| GT199900151A (es) | Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial. | |
| AU7465087A (en) | Controlled release bioerodible drug delivery system | |
| ATE295157T1 (de) | Mittel zur transdermalen verabreichung von arzneistoffen | |
| DE69506007D1 (de) | Transdermales system zur gleichzeitigen verabreichung von mehreren wirkstoffen | |
| DE3650189D1 (de) | Mittel zur nichsystemischen Verabreichung von Sedativa und Analgetika. | |
| PT693924E (pt) | Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos | |
| ES2007100A6 (es) | Procedimiento para la obtencion de un sistema terapeutico oral a base de carbamazepina. | |
| NO920832D0 (no) | Faststoffmatrikssystem for transdermal medikamentavlevering | |
| RU94032150A (ru) | Лекарственное средство с замедленным высвобождением активно-действующего вещества | |
| DE3879853D1 (de) | Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien. | |
| TR200000149T2 (tr) | Serebral nörovasküler bozuklukların, müsküler baş ağrılarının önlenmesine yönelik kompozisyonlar | |
| PT1003477E (pt) | Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel | |
| HUP9901890A2 (hu) | Gyógyszer és eljárás szervezet gyógyszeres kezelésére | |
| ES2016620B3 (es) | Sistema para liberar medicamentos con bioaceptabilidad mejorada. | |
| FR2735132B1 (fr) | Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant | |
| ATE208200T1 (de) | Transdermales therapeutisches system (tts) zur verabreichung von testosteron | |
| DE50000864D1 (de) | Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit | |
| ATE280575T1 (de) | Transdermales therapeutisches system zur anwendung von candesartan | |
| DE69803670D1 (de) | Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung | |
| ATE302010T1 (de) | Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus | |
| DE69727222D1 (de) | Zusammensetzung und system zur iontophoretischen transdermalen abgabe von medikamenten | |
| AU2503900A (en) | Sulfated phosphatidylinositols, their preparation and use | |
| NO963143D0 (no) | Oral legemiddelform inneholdende colestipol som bærer med sure virkestoffer og fremgangsmåte ved fremstilling av denne | |
| DE60028207D1 (de) | Transdermales therapeutisches system zur verabreichung von calciumantagonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |